BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15196056)

  • 1. Statins in solid organ transplantation: is there an immunosuppressive effect?
    Kobashigawa JA
    Am J Transplant; 2004 Jul; 4(7):1013-8. PubMed ID: 15196056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and cardiac allograft vasculopathy after heart transplantation.
    Kobashigawa JA
    Semin Vasc Med; 2004 Nov; 4(4):401-6. PubMed ID: 15861321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins as immunosuppressive agents.
    Kobashigawa JA
    Liver Transpl; 2001 Jun; 7(6):559-61. PubMed ID: 11443589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Navaneethan SD; Perkovic V; Johnson DW; Nigwekar SU; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2009 Apr; (2):CD005019. PubMed ID: 19370615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins in heart transplantation.
    Kittleson MM; Kobashigawa JA
    Clin Transpl; 2013; ():135-43. PubMed ID: 25095502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins.
    Shimizu K; Aikawa M; Takayama K; Libby P; Mitchell RN
    Circulation; 2003 Oct; 108(17):2113-20. PubMed ID: 14517172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the potential benefits of statins in general medical practice be extrapolated to liver transplantation?
    Neal DA; Alexander GJ
    Liver Transpl; 2001 Dec; 7(12):1009-14. PubMed ID: 11753902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and solid organ transplantation.
    Gazi IF; Liberopoulos EN; Athyros VG; Elisaf M; Mikhailidis DP
    Curr Pharm Des; 2006; 12(36):4771-83. PubMed ID: 17168777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual roles of HMG-CoA reductase inhibitors in solid organ transplantation: lipid lowering and immunosuppression.
    Katznelson S; Kobashigawa JA
    Kidney Int Suppl; 1995 Dec; 52():S112-5. PubMed ID: 8587272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins as novel immunomodulators: from cell to potential clinical benefit.
    Mach F
    Thromb Haemost; 2003 Oct; 90(4):607-10. PubMed ID: 14515180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory effects of HMG-CoA reductase inhibitors.
    Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
    Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and tolerability of high-intensity statin therapy in heart transplant patients receiving immunosuppression with tacrolimus.
    Heeney SA; Tjugum SL; Corkish ME; Hollis IB
    Clin Transplant; 2019 Jan; 33(1):e13454. PubMed ID: 30485535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins as immunomodulators.
    Mach F
    Transpl Immunol; 2002 May; 9(2-4):197-200. PubMed ID: 12180830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact and management of hyperlipidemia posttransplantation.
    Fellström B
    Transplantation; 2000 Dec; 70(11 Suppl):SS51-7. PubMed ID: 11152232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hyperlipidaemia associated with heart transplantation.
    Wenke K
    Drugs; 2004; 64(10):1053-68. PubMed ID: 15139786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential immunosuppressive effects of statins.
    Kobashigawa JA
    Pediatr Transplant; 2008 Jun; 12(4):381-4. PubMed ID: 18331542
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute renal allograft rejections, a role for statins?
    Holdaas H; Jardine A
    Minerva Urol Nefrol; 2003 Jun; 55(2):111-9. PubMed ID: 12847415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survival.
    Younas N; Wu CM; Shapiro R; McCauley J; Johnston J; Tan H; Basu A; Schaefer H; Smetanka C; Winkelmayer WC; Unruh M
    BMC Nephrol; 2010 Apr; 11():5. PubMed ID: 20359353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
    Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.